Total metabolic tumor volume by 18F-FDG PET/CT for the prediction of outcome in patients with non-small cell lung cancer.
18F-FDG PET/CT
Metabolic tumor volume
Non-small cell lung cancer
Prognosis
Total lesion glycolysis
Journal
Annals of nuclear medicine
ISSN: 1864-6433
Titre abrégé: Ann Nucl Med
Pays: Japan
ID NLM: 8913398
Informations de publication
Date de publication:
Dec 2019
Dec 2019
Historique:
received:
24
07
2019
accepted:
29
09
2019
pubmed:
16
10
2019
medline:
9
4
2020
entrez:
16
10
2019
Statut:
ppublish
Résumé
Metabolic tumor volume (MTV) and total lesion glycolysis (TLG) are imaging parameters derived from 18F-FDG PET/CT that have been proposed for risk stratification of cancer patients. The aim of our study was to test whether these whole-body volumetric imaging parameters may predict outcome in patients with non-small cell lung cancer (NSCLC). Sixty-five patients (45 men, 20 women; mean age ± SD, 65 ± 12 years), with histologically proven NSCLC who had undergone 18F-FDG PET/CT scan before any therapy, were included in the study. Imaging parameters including SUV A total of 298 lesions were analyzed including 65 primary tumors, 114 metastatic lymph nodes and 119 distant metastases. MTV Whole-body PET-based volumetric imaging parameters are able to predict outcome in NSCLC patients.
Identifiants
pubmed: 31612416
doi: 10.1007/s12149-019-01407-z
pii: 10.1007/s12149-019-01407-z
doi:
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM